Wisdom Pharmaceutical and Coontai reached a deep strategic cooperation.

On August 6th, Ruizhi Medical Technology Co., Ltd. signed a deep strategic cooperation agreement with Guangzhou Kunte Biopharmaceutical Technology Co., Ltd. In the future, both parties will focus on the discovery and evaluation of various modal drugs, further leverage their respective strengths, uphold the basic principle of win-win cooperation, and explore the construction of an ecological model suitable for the rapid development of domestic innovative drugs in preclinical in vitro and in vivo pharmacology, pharmacokinetics and pharmacodynamics, drug metabolism and bioanalysis, safety evaluation, and CDMO and other key links.